Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury
- PMID: 9666085
- DOI: 10.1016/s0006-8993(98)00398-9
Effects of adrenal medullary transplants on pain-related behaviors following excitotoxic spinal cord injury
Abstract
Previous studies have shown that intraspinal injection of quisqualic acid (QUIS) produces excitotoxic injury with pathological characteristics similar to those associated with ischemic and traumatic spinal cord injury (SCI). Significant changes in the functional properties of sensory neurons adjacent to the site of injury have also been observed in this model. Additionally, following QUIS injections, mechanical and cold allodynia, combined with excessive grooming behavior have been shown to be the behavioral correlates of these pathological and physiological changes. These behaviors are believed to be related to the clinical conditions of spontaneous and evoked pain following SCI. Given the therapeutic properties of adrenal chromaffin cell transplantation in conditions of neuropathic and cancer pain, it is proposed that the neuroactive substances released from chromaffin cells can alter or prevent the onset and progression of QUIS-induced behavioral changes. The effects of adrenal transplants were evaluated in 14 male Long-Evans rats that received intraspinal injections of QUIS. Pain behaviors, including the progression of excessive grooming behavior (n=8) and hypersensitivity to mechanical and thermal stimuli (n=6) were evaluated following transplantation. A 53% increase in mechanical thresholds was observed following adrenal transplants along with a 70% reduction in the area of skin targeted for excessive grooming. These behaviors were not affected in 11 animals receiving transplants of skeletal muscle. The effects of adrenal transplants on cold allodynia consisted of a stabilization of response latencies in contrast to the continued decrease in latencies, i.e., increased sensitivity, following transplants of skeletal muscle. The results are consistent with previous studies showing the therapeutic efficacy of adrenal chromaffin cell transplants in neuropathic pain, and support the use of this treatment strategy for the alleviation of chronic pain following spinal cord injury.
Copyright 1998 Elsevier Science B.V. All rights reserved.
Similar articles
-
Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury.Pain. 2001 Feb 1;90(1-2):181-90. doi: 10.1016/s0304-3959(00)00402-4. Pain. 2001. PMID: 11166985
-
Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model.Pain. 1998 Mar;75(1):141-155. doi: 10.1016/S0304-3959(97)00216-9. Pain. 1998. PMID: 9539683
-
The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.Neuroscience. 2001;104(3):863-74. doi: 10.1016/s0306-4522(01)00134-8. Neuroscience. 2001. PMID: 11440816
-
Pain following spinal cord injury: pathophysiology and central mechanisms.Prog Brain Res. 2000;129:429-49. doi: 10.1016/S0079-6123(00)29033-X. Prog Brain Res. 2000. PMID: 11098709 Review. No abstract available.
-
Cell therapy for neuropathic pain in spinal cord injuries.Expert Opin Biol Ther. 2004 Dec;4(12):1861-9. doi: 10.1517/14712598.4.12.1861. Expert Opin Biol Ther. 2004. PMID: 15571449 Review.
Cited by
-
Predifferentiated GABAergic neural precursor transplants for alleviation of dysesthetic central pain following excitotoxic spinal cord injury.Front Physiol. 2012 May 31;3:167. doi: 10.3389/fphys.2012.00167. eCollection 2012. Front Physiol. 2012. PMID: 22754531 Free PMC article.
-
Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice.Mol Med. 2006 Jan-Mar;12(1-3):34-46. doi: 10.2119/2006-00014.Hendricks. Mol Med. 2006. PMID: 16838066 Free PMC article.
-
PTEN/PI3K and MAPK signaling in protection and pathology following CNS injuries.Front Biol (Beijing). 2013 Aug 1;8(4):10.1007/s11515-013-1255-1. doi: 10.1007/s11515-013-1255-1. Front Biol (Beijing). 2013. PMID: 24348522 Free PMC article.
-
Potential for Cell-Transplant Therapy with Human Neuronal Precursors to Treat Neuropathic Pain in Models of PNS and CNS Injury: Comparison of hNT2.17 and hNT2.19 Cell Lines.Pain Res Treat. 2012;2012:356412. doi: 10.1155/2012/356412. Epub 2012 Apr 24. Pain Res Treat. 2012. PMID: 22619713 Free PMC article.
-
Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.Pain Res Treat. 2012;2012:263972. doi: 10.1155/2012/263972. Epub 2012 Jun 14. Pain Res Treat. 2012. PMID: 22745903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical